← Leaderboards
Daniel K Borger
Albert Einstein College Of Medicine
$203,740
Attributed
$203,740
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51.8K · FY2020–23$100K$75K$50K$25K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$203,740 · 1
By mechanism
F30$203,740 · 1
Top collaborators
No co-investigators on record.
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Chandan Guha$30,646,840
- Preeti Viswanathan$837,420
- Ulrich Steidl$14,632,610
- Britta Will$4,590,997
- Fajun James Yang$8,579,386
Others in their field
Other Emerging Leaders on “Face”
- Scott Dahm · Association Of Universities For Research In Astronomy, Inc.$39,961,632
- Robert D Blum · Association Of Universities For Research In Astronomy, Inc.$30,497,056
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Ashlee Fitch · Steelworker Charitable/Educational Org$9,472,828
- Noel Todd Brewer · Univ Of North Carolina Chapel Hill$9,308,531
Research focus
FaceFutureAllelesCrispr CorrectionFlow CytometryAffectBinding ProteinsAutologousAutomobile DrivingCausal VariantCell CountAmino AcidsCell Differentiation ProcessCell MaintenanceCell PhysiologyCell ProliferationCellsBlood TreatmentBone MarrowCell TypeCoculture TechniquesCollaborationsCrispr/Cas TechnologyGene Correction
Grant awards (4)
Developing a novel ex vivo platform to support hematopoietic cells and characterize the stem cell niche$50,432
F30 · FY2023 · HL · contact PI
Developing a novel ex vivo platform to support hematopoietic cells and characterize the stem cell niche$51,752
F30 · FY2022 · HL · contact PI
Developing a novel ex vivo platform to support hematopoietic cells and characterize the stem cell niche$51,036
F30 · FY2021 · HL · contact PI
Developing a novel ex vivo platform to support hematopoietic cells and characterize the stem cell niche$50,520
F30 · FY2020 · HL · contact PI